Senanayake_2020_Antigenic.pdf (173.78 kB)
Can antigenic drift of SARS-CoV-2 spike protein jeopardize current vaccine development?
journal contribution
posted on 2020-07-21, 07:08 authored by Suranga L SenanayakeAn effective vaccine against COVID-19 is widely considered the most promising exit
strategy from the gravest pandemic in over a century. There were over 70 candidates employing diverse technology platforms as reported by the WHO in April 2020, most targeting the spike (S) protein/subunits of SARS-CoV-21
History
Publication
American journal of Virology & Disease;2(2), pp. 01-02Publisher
ONMY Publishing GroupNote
peer-reviewedLanguage
EnglishUsage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC